ADAM10 and Alzheimer disease: Our Western blot and immunohistochemistry results proved that YXQN increased the levels of CTFα and sAPPα by the higher expression of ADAM10 (Figures 6C, 7), to play a neurotropic function against amyloidosis formation in AD mice.